by Bob Yirka, Medical Xpress A model showing Alda-1 bound to ALDH2, with the catalytic tunnel of ALDH2 enlarged (B). Credit: H. Guo, et al., Science Translational Medicine (2023) A team of researchers at Stanford University working with two colleagues from Greenstone Biosciences has found that an SGLT2 inhibitor can reduce endothelial dysfunction commonly associated with the ALDH2 alcohol...
by American College of Physicians Credit: Unsplash/CC0 Public Domain A systematic review and meta-analysis of randomized control trials (RCTs) found that sodium-glucose cotransporter-2 (SGLT2) inhibitors reduce hospitalizations and may reduce cardiovascular deaths among people experiencing heart failure regardless of the presence of diabetes. These findings support existing guidelines that recommend SGLT2 inhibitors for preventing incident...
Drug Canagliflozin is designed to lower blood sugar levels and keep weight off New study reveals it also has an impact on cardiovascular and kidney problems But more work is needed to find out why users more likley to need amputations A cheap anti-diabetes drug slashes the risk of heart attacks and kidney disease, a...
